In one study, primary melanoma cells (M160915) and established cell lines (A375, WM983A, UACC903) with resistance to the BRAF inhibitor dabrafenib were analyzed and it was found that the AR and its downstream pathway were upregulated [49]. This evidence concerns the gene BRAF and melanoma.